Erratum to: Endometrial Cancer

2,140 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, background): “vant therapy? The majority of patients with endometrial cancer have a low risk of recurrence and are managed by surgery alone [110].”
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015, background): “The majority of patients with endometrial cancer have a low risk of recurrence and are managed by surgery alone.(110) Risk groups have been devised based on clinicopathological prognostic factors to identify patients at risk of recurrence who may benefit from adjuvant therapy.”
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening (2018, background): “The evaluation of endometrial histology with the endometrial biopsy is still the standard for determining the status of the endometrium.(91) Women at high risk should be informed that the recommendation for screening is based on expert opinion, and they also should be informed about the potential be”